pharmaceutical giants
pharmaceutical giants Articles
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
Published:
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists...
Published: